Portfolio Update - Replacemen

RNS Number : 7504Q

Intl. Biotechnology Trust PLC

17 April 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the 'Company')    

Amending announcement

The Company advises that the following replaces the Portfolio Update announcement released erroneously on 16 April 2009 at 15.02 pm under RNS Number 6986Q.

Due to an administrative error, Gilead Sciences and Celgene appeared in the wrong order within the Top Ten Holdings. The heading of this table should have also been stated as Ten Largest Quoted Investments. All other details remain the same and the full corrected version of the announcement is shown below:        

Portfolio update as at 31 March 2009                    

Total Net Asset Value ('NAV')

£92.3 million

Ten Largest Quoted Investments

Company Name	% NAV
Micromet	5.5
Celgene	5.3
Gilead Sciences	5.1
Amgen	4.6
Alexion Pharmaceuticals	3.4
Affymax	2.8
Wright Medical	2.8
Celera	2.7
OSI Pharmaceuticals	2.6
Halozyme Therapeutics	2.6
	-----------
Total	37.4

Geographical Split	%
United States	81
Europe	15
Cash	4
	-----------
Total	100

Unquoted/Quoted Split	%
Unquoted	26
Quoted	70
Cash	4
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

17 APRIL 2009

 

END

 

 

PFUIRMLTMMABMPL